MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-27-2026
Inogen EV/EBITDA Ratio 2011-2026 | INGN
Annual EV/EBITDA Ratio Inogen
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 17.4 | 130 | 23.5 | 60.8 | 61.9 | 32.5 | 19.9 | 19.4 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 130 | 17.4 | 45.7 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 11.1 | -0.72 % | $ 314 M |  USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
Electromed
ELMD
|
26.4 | $ 25.81 | 0.98 % | $ 218 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.16 | - | $ 1.31 M | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
730 | $ 3.45 | 3.29 % | $ 129 M |  France |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.61 | -2.42 % | $ 38 M | USA |
 |
Delcath Systems
DCTH
|
-1.69 | $ 11.53 | 4.63 % | $ 413 M | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
LivaNova PLC
LIVN
|
215 | $ 57.59 | -2.51 % | $ 3.14 B |  Britain |
 |
LENSAR
LNSR
|
-1.48 | $ 5.48 | -1.44 % | $ 65.5 M | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
Insulet Corporation
PODD
|
95.3 | $ 167.53 | -2.25 % | $ 11.8 B | USA |
 |
Inspire Medical Systems
INSP
|
-152 | $ 48.25 | -12.02 % | $ 1.42 B | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.05 | -3.23 % | $ 17.8 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
0.974 | $ 2.42 | - | $ 6.71 M | USA |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-165 | $ 17.04 | 7.98 % | $ 400 M | USA |
 |
Butterfly Network
BFLY
|
-3.9 | $ 4.82 | -0.52 % | $ 1.02 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | USA |
 |
TransMedics Group
TMDX
|
-12.1 | $ 94.93 | -2.21 % | $ 3.23 B | USA |
 |
Tandem Diabetes Care
TNDM
|
215 | $ 19.42 | -2.26 % | $ 1.32 B | USA |
 |
Globus Medical
GMED
|
27.6 | $ 90.03 | -0.63 % | $ 12.2 B | USA |
 |
NanoVibronix
NAOV
|
0.955 | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 36.64 | 2.12 % | $ 1.14 B | USA |
 |
Stryker Corporation
SYK
|
30 | $ 295.25 | 1.5 % | $ 113 B | USA |
 |
Integer Holdings Corporation
ITGR
|
18.2 | $ 85.85 | 2.26 % | $ 2.98 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
39.2 | $ 82.91 | -0.5 % | $ 48.5 B | USA |
 |
Pulmonx Corporation
LUNG
|
-22.5 | $ 1.27 | -4.51 % | $ 51.7 M | USA |
 |
MiMedx Group
MDXG
|
-669 | $ 3.64 | 0.83 % | $ 538 M | USA |
 |
Myomo
MYO
|
-2.96 | $ 0.88 | 1.69 % | $ 36.8 M | USA |